Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Mitogen-activated protein kinase (MAPK) >  MEK inhibitor >  PD318088

PD318088

Basic information Safety Supplier Related

PD318088 Basic information

Product Name:
PD318088
Synonyms:
  • PD318088
  • BenzaMide, 5-broMo-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)aMino]-
  • 5-Bromo-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
  • PD318088/PD-318088
  • 5-Bromo-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4- iodophenyl)amino]benzamide PD 318088
  • PD318088, >=98%
  • PD318088;PD 318088;PD-318088
  • CS-395
CAS:
391210-00-7
MF:
C16H13BrF3IN2O4
MW:
561.09
Product Categories:
  • MAPK
  • Inhibitors
Mol File:
391210-00-7.mol
More
Less

PD318088 Chemical Properties

Density 
1.993
storage temp. 
Store at -20°C
solubility 
≥28.05 mg/mL in DMSO; insoluble in H2O; ≥7.36 mg/mL in EtOH with ultrasonic
form 
solid
pka
13.42±0.20(Predicted)
color 
Light yellow to yellow
More
Less

Safety Information

HS Code 
2924297099
More
Less

PD318088 Usage And Synthesis

Biological Activity

pd318088 is an allosteric and non-atp competitive mek1/2 inhibitor.pd318088 is an analog of pd184352, which means it might have important anti-proliferative activity against cancer cells, although no functional study of pd318088 is currently available. pd318088 binds simultaneously with atp in a region of the mek1 active site that is adjacent to the atp-binding site. formation of the ternary complexes with pd318088 and mgatp results in moderate increases (to 140 nm) for the kd monomer-dimer for both mek1 and mek2. pd318088 and mgatp together increase the dimerization disassociation constant for mek1 and mek2 slightly from ~75 nm to ~140 nm [1].pd318088 is a biarylamine compound co-crystallized with mek. g8935 occupies the unique pocket adjacent to atp binding site and is uperimposed with pd318088 .pd318088 averts to use the pocket formed by ile216, phe209, arg189, and asp190. [2]

target

MEK1/2

References

1. ohren jf1, chen h, pavlovsky a et al. structures of human map kinase kinase 1 (mek1) and mek2 describe novel noncompetitive kinase inhibition. nat struct mol biol. 2004 dec;11(12):1192-7. epub 2004 nov 14.2. han s, zhou v, pan s et al. identification of coumarin derivatives as a novel class of allosteric mek1 inhibitors. bioorg med chem lett. 2005 dec 15;15(24):5467-73. epub 2005 sep 30.

PD318088Supplier

Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783
Email
sales@trio-pharmatech.com (International market)
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
meilunui@163.com
Nanjing JinruiJiuAn Biotechnology Co., Ltd.
Tel
025-58196018 800028039
Email
sales@fartop.net
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988